Loading...
Loading...
Among the 5 tracked institutional investors we monitor, LGND (LIGAND PHARMACEUTICALS INC) is held with a combined value of $1.26B across 6,430,794 shares. The largest holder is BlackRock, Inc. with a position worth $591.35M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings.
Total Institutional Value
$1.26B
Total Shares Held
6,430,794
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $591.35M | 0.01% | +0.7% |
| 2 | VANGUARD GROUP INC | $392.11M | 0.01% | New |
| 3 | STATE STREET CORP | $155.50M | 0.01% | +3.7% |
| 4 | FMR LLC | $119.02M | 0.01% | +2.9% |
| 5 | CITADEL ADVISORS LLC | $3.99M | 0.00% | +54.2% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of LGND with a position worth $591.35M, representing 0.01% of their portfolio. In total, 5 institutional investors hold LGND with a combined value of $1.26B.
In the most recent quarter, 1 fund opened a new position in LGND. Additionally, 4 increased their holdings.
Institutional investors hold $1.26B worth of LGND stock across 5 positions. The largest institutional holder is BlackRock, Inc. with $591.35M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LGND, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LGND positions.